Tibet Aim Pharm Inc (002826) — Capital Reinvestment Ratio
Tibet Aim Pharm Inc (002826) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥87.55 Million) in capital expenditures (CN¥3.02 Million). See 002826 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tibet Aim Pharm Inc Capital Reinvestment Ratio (2013–2025)
This chart tracks Tibet Aim Pharm Inc's Capital Reinvestment Ratio across 12 annual periods. Check Tibet Aim Pharm Inc (002826) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Tibet Aim Pharm Inc (2013–2025)
Year-by-year Capital Reinvestment Ratio for Tibet Aim Pharm Inc from 2013 to 2025. For live market cap and broader valuation context, see 002826 company net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | CN¥123.72 Million | CN¥8.50 Million | ▼ -37.4% |
| 2024 | 0.11x | CN¥111.57 Million | CN¥12.24 Million | ▲ +475.7% |
| 2023 | 0.02x | CN¥166.88 Million | CN¥3.18 Million | ▼ -59.2% |
| 2022 | 0.05x | CN¥68.45 Million | CN¥3.20 Million | ▼ -79.7% |
| 2021 | 0.23x | CN¥109.52 Million | CN¥25.20 Million | ▼ -39.1% |
| 2020 | 0.38x | CN¥101.74 Million | CN¥38.43 Million | ▼ -86.9% |
| 2019 | 2.88x | CN¥59.20 Million | CN¥170.45 Million | ▼ -43.4% |
| 2018 | 5.09x | CN¥13.31 Million | CN¥67.72 Million | ▲ +426.8% |
| 2017 | 0.97x | CN¥77.29 Million | CN¥74.62 Million | ▲ +198.0% |
| 2016 | 0.32x | CN¥57.18 Million | CN¥18.52 Million | ▼ -98.4% |
| 2014 | 20.66x | CN¥2.18 Million | CN¥45.12 Million | ▲ +3671.3% |
| 2013 | 0.55x | CN¥52.24 Million | CN¥28.62 Million | — |